Globus Medical, Inc. – NYSE:GMED
Founder-led company
Globus Medical stock price today
$57.593
-25.96
-31.08%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 17 hours
Globus Medical stock price monthly change
+17.57%
month
Globus Medical stock price quarterly change
+17.57%
quarter
Globus Medical stock price yearly change
+57.19%
year
Globus Medical key metrics
Market Cap | 11.22B |
Enterprise value | N/A |
P/E | 31.32 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | 5.69 |
Price/Book | 3.15 |
PEG ratio | 1.13 |
EPS | 0.63 |
Revenue | 1.89B |
EBITDA | 397.77M |
Income | 66.62M |
Revenue Q/Q | 119.25% |
Revenue Y/Y | 77.59% |
Profit margin | 18.59% |
Oper. margin | 23.1% |
Gross margin | 74.22% |
EBIT margin | 23.1% |
EBITDA margin | 20.95% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeGlobus Medical stock price history
Globus Medical stock forecast
Globus Medical financial statements
Average Price Target
$85
Potential upside: 47.58%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 291.61M | 57.71M | 19.79% |
|---|---|---|---|
| Sep 2023 | 383.63M | 998K | 0.26% |
| Dec 2023 | 616.53M | 15.03M | 2.44% |
| Mar 2024 | 606.66M | -7.11M | -1.17% |
| Jun 2023 | 2212465000 | 227.4M | 10.28% |
|---|---|---|---|
| Sep 2023 | 5355875000 | 1.16B | 21.82% |
| Dec 2023 | 5086083000 | 1.08B | 21.39% |
| Mar 2024 | 4943612000 | 1.02B | 20.66% |
| Jun 2023 | 35.02M | 52.22M | 1.08M |
|---|---|---|---|
| Sep 2023 | 50.48M | -80.86M | 1.42M |
| Dec 2023 | 104.67M | 320.61M | -237.27M |
| Mar 2024 | 52.38M | -46.58M | -115.72M |
Globus Medical alternative data
| Aug 2023 | 2,600 |
|---|---|
| Sep 2023 | 2,600 |
| Oct 2023 | 2,600 |
| Nov 2023 | 2,600 |
| Dec 2023 | 2,600 |
| Jan 2024 | 2,600 |
| Feb 2024 | 2,600 |
| Mar 2024 | 5,000 |
| Apr 2024 | 5,000 |
| May 2024 | 5,000 |
| Jun 2024 | 5,000 |
| Jul 2024 | 5,000 |
Globus Medical other data
64.51%
-5.00%
of GMED is owned by hedge funds
329
-19
66.37M
-5.97M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Mar 2024 | 0 | 18090 |
| May 2024 | 0 | 83300 |
| Jul 2024 | 0 | 1000 |
| Sep 2024 | 0 | 40000 |
| Oct 2024 | 0 | 57500 |
| Nov 2024 | 0 | 249375 |
| Dec 2024 | 0 | 2500 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Option | HULLER KELLY officer: SVP, GC,.. | Class A Common Stock | 2,500 | $24.21 | $60,525 | ||
Sale | HULLER KELLY officer: SVP, GC,.. | Class A Common Stock | 2,500 | $87 | $217,503 | ||
Option | HULLER KELLY officer: SVP, GC,.. | Stock Option (Right to Buy Class A Common Stock) | 2,500 | $24.21 | $60,525 | ||
Sale | DAVIDAR DAVID D director | Class A Common Stock | 6,766 | $85 | $575,137 | ||
Sale | DAVIDAR DAVID D director | Class A Common Stock | 6,746 | $85 | $573,437 | ||
Option | LEMAITRE DAN director | Class A Common Stock | 1,097 | $65.05 | $71,360 | ||
Option | LEMAITRE DAN director | Stock Option (Right to Buy Class A Common Stock) | 1,097 | $65.05 | $71,360 | ||
Sale | LEMAITRE DAN director | Class A Common Stock | 1,097 | $85.02 | $93,264 | ||
Sale | DAVIDAR DAVID D director | Class A Common Stock | 13,234 | $85 | $1,124,890 | ||
Sale | DAVIDAR DAVID D director | Class A Common Stock | 13,254 | $85 | $1,126,590 |
| Patent |
|---|
Grant Filling date: 20 Jan 2021 Issue date: 20 Sep 2022 |
Grant Filling date: 6 Nov 2020 Issue date: 20 Sep 2022 |
Grant Filling date: 24 Jun 2020 Issue date: 20 Sep 2022 |
Grant Utility: Self in-fusing pedicle screw implant Filling date: 13 Nov 2019 Issue date: 20 Sep 2022 |
Grant Utility: MIS cross-connector Filling date: 17 Jul 2019 Issue date: 20 Sep 2022 |
Grant Utility: Screw tower and rod reduction tool Filling date: 22 Jul 2021 Issue date: 13 Sep 2022 |
Grant Filling date: 22 Jan 2019 Issue date: 13 Sep 2022 |
Grant Utility: Surgical tool system and method Filling date: 16 Oct 2018 Issue date: 13 Sep 2022 |
Application Filling date: 25 May 2022 Issue date: 8 Sep 2022 |
Application Filling date: 25 May 2022 Issue date: 8 Sep 2022 |
| Quarter | Transcript |
|---|---|
| Q1 2024 7 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 20 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 7 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 3 Aug 2023 | Q2 2023 Earnings Call Transcript |
Globus Medical: NuVasive Merger Unlocks Incremental NOPAT Growth
Alphatec Holdings: Taking Market Share Amid Strong Execution - Buy
Globus Medical: Merger Overhang Lingering
Globus Medical: Almost Having My Back
Globus Medical: Robotics Demand Ratcheting Higher, Reiterate Buy
Globus Medical: Still Very Attractive After NuVasive Selloff
Globus And NuVasive Take Spinal Fusion To A New Level
Intuitive Surgical: Valuation Hanging On By The $4 Billion Cash Thread
Globus Medical: An Impressive Long-Term Revenue Growth Play
-
What's the price of Globus Medical stock today?
One share of Globus Medical stock can currently be purchased for approximately $57.59.
-
When is Globus Medical's next earnings date?
Unfortunately, Globus Medical's (GMED) next earnings date is currently unknown.
-
Does Globus Medical pay dividends?
No, Globus Medical does not pay dividends.
-
How much money does Globus Medical make?
Globus Medical has a market capitalization of 11.22B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 53.34% to 1.57B US dollars.
-
What is Globus Medical's stock symbol?
Globus Medical, Inc. is traded on the NYSE under the ticker symbol "GMED".
-
What is Globus Medical's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Globus Medical?
Shares of Globus Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Globus Medical's key executives?
Globus Medical's management team includes the following people:
- Mr. David M. Demski Chief Executive Officer, Pres & Director(age: 67, pay: $1,480,000)
- Mr. David C. Paul Co-Founder & Executive Chairman(age: 58, pay: $965,080)
- Mr. Daniel T. Scavilla Executive Vice President, Chief Commercial Officer & Pres of Trauma(age: 60, pay: $864,450)
- Mr. Keith W. Pfeil Senior Vice President & Chief Financial Officer(age: 46, pay: $619,870)
- Ms. Kelly G. Huller Esq. Senior Vice President & Gen. Counsel(age: 52, pay: $504,260)
-
Is Globus Medical founder-led company?
Yes, Globus Medical is a company led by its founder Mr. David C. Paul.
-
How many employees does Globus Medical have?
As Jul 2024, Globus Medical employs 5,000 workers.
-
When Globus Medical went public?
Globus Medical, Inc. is publicly traded company for more then 13 years since IPO on 3 Aug 2012.
-
What is Globus Medical's official website?
The official website for Globus Medical is globusmedical.com.
-
Where are Globus Medical's headquarters?
Globus Medical is headquartered at 2560 General Armistead Avenue, Audubon, PA.
-
How can i contact Globus Medical?
Globus Medical's mailing address is 2560 General Armistead Avenue, Audubon, PA and company can be reached via phone at +61 9301800.
-
What is Globus Medical stock forecast & price target?
Based on 3 Wall Street analysts` predicted price targets for Globus Medical in the last 12 months, the avarage price target is $85. The average price target represents a 47.58% change from the last price of $57.59.
Globus Medical company profile:
Globus Medical, Inc.
globusmedical.comExchange:
NYSE
Full time employees:
5,000
Industry:
Medical - Devices
Sector:
Healthcare
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
2560 General Armistead Avenue
Audubon, PA 19403
Audubon, PA 19403
CIK: 0001237831
ISIN: US3795772082
CUSIP: 379577208
